Literature DB >> 18682243

Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture.

Jonas Larsson1, Masanobu Ohishi, Brian Garrison, Marie Aspling, Viktor Janzen, Gregor B Adams, Marcello Curto, Andrea I McClatchey, Ernestina Schipani, David T Scadden.   

Abstract

Stem cell population size is highly regulated across species and tissue types, and alterations are associated with premature tissue failure or cancer. We assessed whether the tumor suppressor and mediator of cell contact inhibition Nf2/merlin plays a role in governing the hematopoietic stem cell pool by stem cell-autonomous or niche-determined processes. Hematopoietic stem cells in Nf2-deficient mice were increased in number and demonstrated a marked shift in location to the circulation. These changes were entirely dependent on changes in the microenvironment, with a marked increase in trabecular bone and marrow vascularity associated with increased VEGF, but without cell-autonomous alterations in stem cell characteristics. Nf2/merlin is critical for maintaining normal structure and function of the hematopoietic stem cell niche. It limits both bone and vascular components, and our model suggests that it thereby constrains stem cell number and position.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682243      PMCID: PMC4197168          DOI: 10.1016/j.stem.2008.06.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  24 in total

Review 1.  Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.

Authors:  Andrea I McClatchey; Marco Giovannini
Journal:  Genes Dev       Date:  2005-10-01       Impact factor: 11.361

2.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Authors:  M Giovannini; E Robanus-Maandag; M van der Valk; M Niwa-Kawakita; V Abramowski; L Goutebroze; J M Woodruff; A Berns; G Thomas
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

3.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.

Authors:  Orit Kollet; Ayelet Dar; Shoham Shivtiel; Alexander Kalinkovich; Kfir Lapid; Yejezkel Sztainberg; Melania Tesio; Robert M Samstein; Polina Goichberg; Asaf Spiegel; Ari Elson; Tsvee Lapidot
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

4.  The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.

Authors:  Sushmita Maitra; Rima M Kulikauskas; Heather Gavilan; Richard G Fehon
Journal:  Curr Biol       Date:  2006-04-04       Impact factor: 10.834

5.  Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments.

Authors:  R Chiusaroli; A Maier; M C Knight; M Byrne; L M Calvi; R Baron; S M Krane; E Schipani
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

6.  Identification of the haematopoietic stem cell niche and control of the niche size.

Authors:  Jiwang Zhang; Chao Niu; Ling Ye; Haiyang Huang; Xi He; Wei-Gang Tong; Jason Ross; Jeff Haug; Teri Johnson; Jian Q Feng; Stephen Harris; Leanne M Wiedemann; Yuji Mishina; Linheng Li
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

7.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

8.  NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.

Authors:  Dominique Lallemand; Marcello Curto; Ichiko Saotome; Marco Giovannini; Andrea I McClatchey
Journal:  Genes Dev       Date:  2003-04-14       Impact factor: 11.361

9.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.

Authors:  Ying Wang; Chao Wan; Lianfu Deng; Ximeng Liu; Xuemei Cao; Shawn R Gilbert; Mary L Bouxsein; Marie-Claude Faugere; Robert E Guldberg; Louis C Gerstenfeld; Volker H Haase; Randall S Johnson; Ernestina Schipani; Thomas L Clemens
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

10.  Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

Authors:  K Hattori; S Dias; B Heissig; N R Hackett; D Lyden; M Tateno; D J Hicklin; Z Zhu; L Witte; R G Crystal; M A Moore; S Rafii
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  16 in total

Review 1.  Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Matthias A Karajannis; Filippo G Giancotti
Journal:  EMBO Rep       Date:  2012-03       Impact factor: 8.807

2.  Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.

Authors:  Samira Benhamouche; Marcello Curto; Ichiko Saotome; Andrew B Gladden; Ching-Hui Liu; Marco Giovannini; Andrea I McClatchey
Journal:  Genes Dev       Date:  2010-07-30       Impact factor: 11.361

3.  Fak depletion in both hematopoietic and nonhematopoietic niche cells leads to hematopoietic stem cell expansion.

Authors:  Jiayun Lu; Yan Sun; Cesar Nombela-Arrieta; Karrie P Du; Shin-Young Park; Li Chai; Carl Walkley; Hongbo R Luo; Leslie E Silberstein
Journal:  Exp Hematol       Date:  2011-12-08       Impact factor: 3.084

4.  Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice.

Authors:  Hoogeun Song; Hyunsoo Kim; Kyunghee Lee; Da-Hye Lee; Tae-Shin Kim; Ji Yun Song; Dongjun Lee; Dongwook Choi; Chang-Yong Ko; Han-Sung Kim; Hong-In Shin; Juhyun Choi; Heedong Park; Chankyu Park; Daewon Jeong; Dae-Sik Lim
Journal:  EMBO J       Date:  2012-01-06       Impact factor: 11.598

Review 5.  Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

Authors:  Ivan Stamenkovic; Qin Yu
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

6.  Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.

Authors:  Christa Maes; Steven Goossens; Sonia Bartunkova; Benjamin Drogat; Lieve Coenegrachts; Ingrid Stockmans; Karen Moermans; Omar Nyabi; Katharina Haigh; Michael Naessens; Lieven Haenebalcke; Jan P Tuckermann; Marc Tjwa; Peter Carmeliet; Vice Mandic; Jean-Pierre David; Axel Behrens; Andras Nagy; Geert Carmeliet; Jody J Haigh
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

7.  Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model.

Authors:  Ana Paula D N de Barros; Christina M Takiya; Luciana R Garzoni; Mona Lisa Leal-Ferreira; Hélio S Dutra; Luciana B Chiarini; Maria Nazareth Meirelles; Radovan Borojevic; Maria Isabel D Rossi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 8.  The hematopoietic stem cell niche--home for friend and foe?

Authors:  Daniela S Krause; David T Scadden; Frederic I Preffer
Journal:  Cytometry B Clin Cytom       Date:  2012-12-26       Impact factor: 3.058

Review 9.  The leukemic stem cell niche: current concepts and therapeutic opportunities.

Authors:  Steven W Lane; David T Scadden; D Gary Gilliland
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

10.  Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer.

Authors:  Mateus S V Mota; William P Jackson; Sarah K Bailey; Praveen Vayalil; Aimee Landar; Jack W Rostas; Madhuri S Mulekar; Rajeev S Samant; Lalita A Shevde
Journal:  Carcinogenesis       Date:  2018-09-21       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.